WallStreetZenWallStreetZen

NASDAQ: ENTA
Enanta Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for ENTA

Based on 3 analysts offering 12 month price targets for Enanta Pharmaceuticals Inc.
Min Forecast
$11.00-31.25%
Avg Forecast
$20.00+25%
Max Forecast
$27.00+68.75%

Should I buy or sell ENTA stock?

Based on 3 analysts offering ratings for Enanta Pharmaceuticals Inc.
Hold
Strong Buy
0 analysts 0%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
1 analysts 33.33%

Be the first to know when Wall Street analysts revise their ENTA stock forecasts and price targets.

ENTA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-07
lockedlocked$00.00+00.00%2024-05-07
lockedlocked$00.00+00.00%2024-02-08

1 of 1

Forecast return on equity

Is ENTA forecast to generate an efficient return?
Company
-52.36%
Industry
73.55%
Market
80.58%
ENTA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ENTA forecast to generate an efficient return on assets?
Company
-21.03%
Industry
31.45%
ENTA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ENTA earnings per share forecast

What is ENTA's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
-$5.95
Avg 2 year Forecast
-$4.99
Avg 3 year Forecast
-$5.46

ENTA revenue forecast

What is ENTA's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$70.2M-3.74%
Avg 2 year Forecast
$76.6M+5.07%
Avg 3 year Forecast
$72.0M-1.27%
ENTA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ENTA revenue growth forecast

How is ENTA forecast to perform vs Biotechnology companies and vs the US market?
Company
0.42%
Industry
37.21%
Market
10.62%
ENTA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ENTA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ENTA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ENTA$16.00$20.00+25.00%Hold
STRO$4.16$12.57+202.19%Strong Buy
VNDA$5.92$11.00+85.81%Strong Buy
XERS$2.36$4.67+98.17%Strong Buy
ADAP$1.28$3.08+140.23%Strong Buy

Enanta Pharmaceuticals Stock Forecast FAQ

Is Enanta Pharmaceuticals Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ENTA) stock is to Hold ENTA stock.

Out of 3 analysts, 0 (0%) are recommending ENTA as a Strong Buy, 2 (66.67%) are recommending ENTA as a Buy, 0 (0%) are recommending ENTA as a Hold, 0 (0%) are recommending ENTA as a Sell, and 1 (33.33%) are recommending ENTA as a Strong Sell.

If you're new to stock investing, here's how to buy Enanta Pharmaceuticals stock.

What is ENTA's earnings growth forecast for 2024-2026?

(NASDAQ: ENTA) Enanta Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 14.45%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.78%.

Enanta Pharmaceuticals's earnings in 2024 is -$131,736,000.On average, 4 Wall Street analysts forecast ENTA's earnings for 2024 to be -$126,070,379, with the lowest ENTA earnings forecast at -$133,430,220, and the highest ENTA earnings forecast at -$115,427,730. On average, 4 Wall Street analysts forecast ENTA's earnings for 2025 to be -$105,579,309, with the lowest ENTA earnings forecast at -$123,264,108, and the highest ENTA earnings forecast at -$99,119,592.

In 2026, ENTA is forecast to generate -$115,639,524 in earnings, with the lowest earnings forecast at -$169,011,612 and the highest earnings forecast at -$66,715,110.

What is ENTA's revenue growth forecast for 2024-2026?

(NASDAQ: ENTA) Enanta Pharmaceuticals's forecast annual revenue growth rate of 0.42% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.21%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.62%.

Enanta Pharmaceuticals's revenue in 2024 is $72,881,000.On average, 5 Wall Street analysts forecast ENTA's revenue for 2024 to be $1,485,861,986, with the lowest ENTA revenue forecast at $1,430,668,470, and the highest ENTA revenue forecast at $1,558,803,840. On average, 5 Wall Street analysts forecast ENTA's revenue for 2025 to be $1,621,876,093, with the lowest ENTA revenue forecast at $1,331,125,290, and the highest ENTA revenue forecast at $2,370,822,036.

In 2026, ENTA is forecast to generate $1,523,984,906 in revenue, with the lowest revenue forecast at $685,365,384 and the highest revenue forecast at $2,314,273,038.

What is ENTA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ENTA) forecast ROA is -21.03%, which is lower than the forecast US Biotechnology industry average of 31.45%.

What is ENTA's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ENTA price target, the average ENTA price target is $20.00, with the highest ENTA stock price forecast at $27.00 and the lowest ENTA stock price forecast at $11.00.

On average, Wall Street analysts predict that Enanta Pharmaceuticals's share price could reach $20.00 by May 7, 2025. The average Enanta Pharmaceuticals stock price prediction forecasts a potential upside of 25% from the current ENTA share price of $16.00.

What is ENTA's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: ENTA) Enanta Pharmaceuticals's current Earnings Per Share (EPS) is -$6.24. On average, analysts forecast that ENTA's EPS will be -$5.95 for 2024, with the lowest EPS forecast at -$6.30, and the highest EPS forecast at -$5.45. On average, analysts forecast that ENTA's EPS will be -$4.99 for 2025, with the lowest EPS forecast at -$5.82, and the highest EPS forecast at -$4.68. In 2026, ENTA's EPS is forecast to hit -$5.46 (min: -$7.98, max: -$3.15).

What is ENTA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ENTA) forecast ROE is -52.36%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.